Clark Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.8K Buy
50
+14
+39% +$8.32K 0.02% 156
2026
Q2
$18.1K Hold
36
– – 0.01% 188
2026
Q1
$17.7K Sell
36
-15
-29% -$8.14K 0.01% 197
2025
Q4
$29.6K Hold
51
– – 0.02% 138
2025
Q3
$29.6K Buy
51
+32
+168% +$14.9K 0.02% 138
2025
Q2
$7.7K Hold
19
– – 0.01% 236
2025
Q1
$9.45K Hold
19
– – 0.01% 204
2024
Q4
$9.9K Buy
+19
New +$10.4K 0.01% 173

Other funds holding TMO

Clark Wealth Partners's TMO Position: Q3 2026 in Review

Clark Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 39% in Q3 2026, buying an estimated $8.32K and bringing the position to 50 shares worth $33.8K. The position accounts for 0.02% of the portfolio, ranked #156.

Clark Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 2,802 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Clark Wealth Partners held 50 shares of Thermo Fisher Scientific worth $33.8K as of Q3 2026.
  • Clark Wealth Partners bought 14 Thermo Fisher Scientific shares in Q3 2026, an estimated $8.32K.
  • Thermo Fisher Scientific made up 0.02% of Clark Wealth Partners's portfolio in Q3 2026, its #156 holding.
  • Clark Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
  • 2,802 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.